Alessia Nottegar

3.1k total citations · 1 hit paper
48 papers, 1.8k citations indexed

About

Alessia Nottegar is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Alessia Nottegar has authored 48 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 15 papers in Pulmonary and Respiratory Medicine and 14 papers in Cancer Research. Recurrent topics in Alessia Nottegar's work include Cancer Genomics and Diagnostics (10 papers), Pancreatic and Hepatic Oncology Research (9 papers) and Lung Cancer Treatments and Mutations (8 papers). Alessia Nottegar is often cited by papers focused on Cancer Genomics and Diagnostics (10 papers), Pancreatic and Hepatic Oncology Research (9 papers) and Lung Cancer Treatments and Mutations (8 papers). Alessia Nottegar collaborates with scholars based in Italy, United States and United Kingdom. Alessia Nottegar's co-authors include Claudio Luchini, Aldo Scarpa, Nicola Veronese, Robert E. Miller, J-Y Douillard, Frédéric Bibeau, Nadeem Riaz, Fabrice André, Naveena Singh and Tjalling Bosse and has published in prestigious journals such as Scientific Reports, International Journal of Molecular Sciences and Annals of Oncology.

In The Last Decade

Alessia Nottegar

47 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

ESMO recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1/PD-L1 expression and tumour mutational burden: a systematic review-based approach

2019 685 citations Claudio Luchini, Alessia Nottegar et al. Annals of Oncology profile →

Peers

Alessia Nottegar

ONCOL

PRM

SURGE

PFM

Beyhan Ataseven Germany

Dieter Koeberle Switzerland

Florian Heitz Germany

Philippe Moerman Belgium

Henry G. Kaplan United States

Emmanuel Gabriel United States

Sabine Schmid Switzerland

Philip C.W. Lui Hong Kong

Yang Feng China

Douglas L. Riegert‐Johnson United States

Beyhan Ataseven Germany

Alessia Nottegar

935 ×1.0

ONCOL

367 ×0.7

PRM

685 ×1.6

593 ×1.4

SURGE

345 ×0.9

PFM

Citations per year, relative to Alessia Nottegar Alessia Nottegar (= 1×) peers Beyhan Ataseven

Countries citing papers authored by Alessia Nottegar

Since Specialization

Citations

This map shows the geographic impact of Alessia Nottegar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alessia Nottegar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alessia Nottegar more than expected).

Fields of papers citing papers by Alessia Nottegar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alessia Nottegar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alessia Nottegar. The network helps show where Alessia Nottegar may publish in the future.

Co-authorship network of co-authors of Alessia Nottegar

This figure shows the co-authorship network connecting the top 25 collaborators of Alessia Nottegar. A scholar is included among the top collaborators of Alessia Nottegar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alessia Nottegar. Alessia Nottegar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Volante, Marco, Filippo Pietrantonio, Martina Olivero, et al.. (2025). Data from AREG and EREG Are Predictive Biomarkers of Response to EGFR Inhibition in Gastroesophageal Cancer. 1 indexed citations

Marletta, Stefano, Alessia Nottegar, Albino Eccher, et al.. (2024). The application of artificial intelligence to thyroid nodule assessment. Diagnostic histopathology. 30(6). 339–343. 2 indexed citations

Mafficini, Andrea, Rita T. Lawlor, Claudio Ghimenton, et al.. (2021). Solid Pseudopapillary Neoplasm of the Pancreas and Abdominal Desmoid Tumor in a Patient Carrying Two Different BRCA2 Germline Mutations: New Horizons from Tumor Molecular Profiling. Genes. 12(4). 481–481. 12 indexed citations

Tabbò, Fabrizio, Francesco Guerrera, Marcello Gaudiano, et al.. (2020). Kinomic profiling of tumour xenografts derived from patients with non–small cell lung cancer confirms their fidelity and reveals potentially actionable pathways. European Journal of Cancer. 144. 17–30. 2 indexed citations

Smith, Lee, Christopher N. Parris, Nicola Veronese, et al.. (2020). Cross-sectional associations between angiotensin-converting enzyme inhibitor use and cancer diagnosis in US adults. Clinical and Experimental Medicine. 20(3). 409–416. 3 indexed citations

Girolami, Ilaria, Nicola Veronese, Lee Smith, et al.. (2019). The Activation Status of the TGF-β Transducer Smad2 Is Associated with a Reduced Survival in Gastrointestinal Cancers: A Systematic Review and Meta-Analysis. International Journal of Molecular Sciences. 20(15). 3831–3831. 7 indexed citations

Luchini, Claudio, Nicola Veronese, Alessia Nottegar, et al.. (2019). Liquid Biopsy as Surrogate for Tissue for Molecular Profiling in Pancreatic Cancer: A Meta-Analysis Towards Precision Medicine. Cancers. 11(8). 1152–1152. 39 indexed citations

Smith, Lee, Claudio Luchini, Jacopo Demurtas, et al.. (2019). Telomere length and health outcomes: An umbrella review of systematic reviews and meta-analyses of observational studies. Ageing Research Reviews. 51. 1–10. 56 indexed citations

Lawlor, Rita T., Nicola Veronese, Alessia Nottegar, et al.. (2019). Prognostic Role of High-Grade Tumor Budding in Pancreatic Ductal Adenocarcinoma: A Systematic Review and Meta-Analysis with a Focus on Epithelial to Mesenchymal Transition. Cancers. 11(1). 113–113. 48 indexed citations

10.

Luchini, Claudio, Nicola Veronese, Alessia Nottegar, et al.. (2018). Extranodal extension of nodal metastases is a poor prognostic moderator in non-small cell lung cancer: a meta-analysis. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 472(6). 939–947. 26 indexed citations

11.

Lawlor, Rita T., Valentina Daprà, Ilaria Girolami, et al.. (2018). CD200 expression is a feature of solid pseudopapillary neoplasms of the pancreas. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 474(1). 105–109. 19 indexed citations

12.

Luchini, Claudio, Achim Fleischmann, Joost L. Boormans, et al.. (2017). Extranodal extension of lymph node metastasis influences recurrence in prostate cancer: a systematic review and meta-analysis. Scientific Reports. 7(1). 2374–2374. 26 indexed citations

13.

Luchini, Claudio, Antonio Pea, Gemma Lionheart, et al.. (2017). Pancreatic undifferentiated carcinoma with osteoclast‐like giant cells is genetically similar to, but clinically distinct from, conventional ductal adenocarcinoma. The Journal of Pathology. 243(2). 148–154. 66 indexed citations

14.

Luchini, Claudio, Scott Robertson, Seung‐Mo Hong, et al.. (2017). PBRM1 loss is a late event during the development of cholangiocarcinoma. Histopathology. 71(3). 375–382. 23 indexed citations

15.

Luchini, Claudio, Laura D. Wood, Liang Cheng, et al.. (2016). Extranodal extension of lymph node metastasis is a marker of poor prognosis in oesophageal cancer: a systematic review with meta-analysis. Journal of Clinical Pathology. 69(11). 956–961. 23 indexed citations

16.

Luchini, Claudio, Alessia Nottegar, Marco Solmi, et al.. (2015). Prognostic implications of extranodal extension in node-positive squamous cell carcinoma of the vulva: A systematic review and meta-analysis. Surgical Oncology. 25(1). 60–65. 39 indexed citations

17.

Luchini, Claudio, Pietro Parcesepe, Andrea Mafficini, et al.. (2015). Specific expression patterns of epithelial to mesenchymal transition factors in gestational molar disease. Placenta. 36(11). 1318–1324. 19 indexed citations

18.

Veronese, Nicola, Alessia Nottegar, Antonio Pea, et al.. (2015). Prognostic impact and implications of extracapsular lymph node involvement in colorectal cancer: a systematic review with meta-analysis. Annals of Oncology. 27(1). 42–48. 71 indexed citations

19.

Caliò, Anna, Alessia Nottegar, Eliana Gilioli, et al.. (2014). ALK/EML4 Fusion Gene May Be Found in Pure Squamous Carcinoma of the Lung. Journal of Thoracic Oncology. 9(5). 729–732. 46 indexed citations

20.

Brunelli, Matteo, Erminia Manfrin, Alessia Nottegar, et al.. (2011). Classical lobular breast carcinoma consistently lacks topoisomerase‐IIα gene amplification: implications for the tailored use of anthracycline‐based chemotherapies. Histopathology. 60(3). 482–488. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact